<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019cb44b-a374-70ca-b242-05d0124c5e9f,g:0717f2d3-70e4-403c-8fbf-c5ceb6f1c9cc-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bhvn="http://www.biohavenpharma.com/20260331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.biohavenpharma.com/20260331">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhvn-20260331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhvn-20260331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhvn-20260331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhvn-20260331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="COVER" roleURI="http://www.biohavenpharma.com/role/COVER">
        <link:definition>0000001 - Document - COVER</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.biohavenpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>9952151 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.biohavenpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>9952152 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" roleURI="http://www.biohavenpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
        <link:definition>9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.biohavenpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureoftheBusinessandBasisofPresentation" roleURI="http://www.biohavenpharma.com/role/NatureoftheBusinessandBasisofPresentation">
        <link:definition>9952155 - Disclosure - Nature of the Business and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.biohavenpharma.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952156 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecurities" roleURI="http://www.biohavenpharma.com/role/MarketableSecurities">
        <link:definition>9952157 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialAssetsandLiabilities" roleURI="http://www.biohavenpharma.com/role/FairValueofFinancialAssetsandLiabilities">
        <link:definition>9952158 - Disclosure - Fair Value of Financial Assets and Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://www.biohavenpharma.com/role/BalanceSheetComponents">
        <link:definition>9952159 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesPayable" roleURI="http://www.biohavenpharma.com/role/NotesPayable">
        <link:definition>9952160 - Disclosure - Notes Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.biohavenpharma.com/role/ShareholdersEquity">
        <link:definition>9952161 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncome" roleURI="http://www.biohavenpharma.com/role/AccumulatedOtherComprehensiveIncome">
        <link:definition>9952162 - Disclosure - Accumulated Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NonCashShareBasedCompensation" roleURI="http://www.biohavenpharma.com/role/NonCashShareBasedCompensation">
        <link:definition>9952163 - Disclosure - Non-Cash Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.biohavenpharma.com/role/NetLossPerShare">
        <link:definition>9952164 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseAcquisitionsandOtherAgreements" roleURI="http://www.biohavenpharma.com/role/LicenseAcquisitionsandOtherAgreements">
        <link:definition>9952165 - Disclosure - License, Acquisitions and Other Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.biohavenpharma.com/role/CommitmentsandContingencies">
        <link:definition>9952166 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.biohavenpharma.com/role/RelatedPartyTransactions">
        <link:definition>9952167 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.biohavenpharma.com/role/SegmentInformation">
        <link:definition>9952168 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.biohavenpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.biohavenpharma.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesTables" roleURI="http://www.biohavenpharma.com/role/MarketableSecuritiesTables">
        <link:definition>9955513 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialAssetsandLiabilitiesTables" roleURI="http://www.biohavenpharma.com/role/FairValueofFinancialAssetsandLiabilitiesTables">
        <link:definition>9955514 - Disclosure - Fair Value of Financial Assets and Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://www.biohavenpharma.com/role/BalanceSheetComponentsTables">
        <link:definition>9955515 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.biohavenpharma.com/role/ShareholdersEquityTables">
        <link:definition>9955516 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeTables" roleURI="http://www.biohavenpharma.com/role/AccumulatedOtherComprehensiveIncomeTables">
        <link:definition>9955517 - Disclosure - Accumulated Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NonCashShareBasedCompensationTables" roleURI="http://www.biohavenpharma.com/role/NonCashShareBasedCompensationTables">
        <link:definition>9955518 - Disclosure - Non-Cash Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.biohavenpharma.com/role/NetLossPerShareTables">
        <link:definition>9955519 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseAcquisitionsandOtherAgreementsTables" roleURI="http://www.biohavenpharma.com/role/LicenseAcquisitionsandOtherAgreementsTables">
        <link:definition>9955520 - Disclosure - License, Acquisitions and Other Agreements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.biohavenpharma.com/role/SegmentInformationTables">
        <link:definition>9955521 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.biohavenpharma.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>9955522 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesAmortizedCostandFairValueofDebtSecuritiesDetails" roleURI="http://www.biohavenpharma.com/role/MarketableSecuritiesAmortizedCostandFairValueofDebtSecuritiesDetails">
        <link:definition>9955523 - Disclosure - Marketable Securities - Amortized Cost and Fair Value of Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesContractualMaturitiesDetails" roleURI="http://www.biohavenpharma.com/role/MarketableSecuritiesContractualMaturitiesDetails">
        <link:definition>9955524 - Disclosure - Marketable Securities - Contractual Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesDebtSecuritiesAvailableforSaleinUnrealizedLossPositionDetails" roleURI="http://www.biohavenpharma.com/role/MarketableSecuritiesDebtSecuritiesAvailableforSaleinUnrealizedLossPositionDetails">
        <link:definition>9955525 - Disclosure - Marketable Securities - Debt Securities Available-for-Sale in Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesNarrativeDetails" roleURI="http://www.biohavenpharma.com/role/MarketableSecuritiesNarrativeDetails">
        <link:definition>9955526 - Disclosure - Marketable Securities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesNetInvestmentIncomeDetails" roleURI="http://www.biohavenpharma.com/role/MarketableSecuritiesNetInvestmentIncomeDetails">
        <link:definition>9955527 - Disclosure - Marketable Securities - Net Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialAssetsandLiabilitiesFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.biohavenpharma.com/role/FairValueofFinancialAssetsandLiabilitiesFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>9955528 - Disclosure - Fair Value of Financial Assets and Liabilities - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialAssetsandLiabilitiesNarrativeDetails" roleURI="http://www.biohavenpharma.com/role/FairValueofFinancialAssetsandLiabilitiesNarrativeDetails">
        <link:definition>9955529 - Disclosure - Fair Value of Financial Assets and Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialAssetsandLiabilitiesRollForwardofAggregateFairValueDeterminedbyLevel3InputsDetails" roleURI="http://www.biohavenpharma.com/role/FairValueofFinancialAssetsandLiabilitiesRollForwardofAggregateFairValueDeterminedbyLevel3InputsDetails">
        <link:definition>9955530 - Disclosure - Fair Value of Financial Assets and Liabilities - Roll Forward of Aggregate Fair Value Determined by Level 3 Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsPropertyandEquipmentNetDetails" roleURI="http://www.biohavenpharma.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails">
        <link:definition>9955531 - Disclosure - Balance Sheet Components - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsNarrativeDetails" roleURI="http://www.biohavenpharma.com/role/BalanceSheetComponentsNarrativeDetails">
        <link:definition>9955532 - Disclosure - Balance Sheet Components - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsOtherNoncurrentAssetsDetails" roleURI="http://www.biohavenpharma.com/role/BalanceSheetComponentsOtherNoncurrentAssetsDetails">
        <link:definition>9955533 - Disclosure - Balance Sheet Components - Other Non-current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails" roleURI="http://www.biohavenpharma.com/role/BalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails">
        <link:definition>9955534 - Disclosure - Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesPayableNarrativeDetails" roleURI="http://www.biohavenpharma.com/role/NotesPayableNarrativeDetails">
        <link:definition>9955535 - Disclosure - Notes Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangesinShareholdersDeficitDetails" roleURI="http://www.biohavenpharma.com/role/ShareholdersEquityChangesinShareholdersDeficitDetails">
        <link:definition>9955536 - Disclosure - Shareholders' Equity - Changes in Shareholders' Deficit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://www.biohavenpharma.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>9955537 - Disclosure - Shareholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.biohavenpharma.com/role/AccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>9955538 - Disclosure - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NonCashShareBasedCompensationNarrativeDetails" roleURI="http://www.biohavenpharma.com/role/NonCashShareBasedCompensationNarrativeDetails">
        <link:definition>9955539 - Disclosure - Non-Cash Share-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NonCashShareBasedCompensationNonCashExpenseDetails" roleURI="http://www.biohavenpharma.com/role/NonCashShareBasedCompensationNonCashExpenseDetails">
        <link:definition>9955540 - Disclosure - Non-Cash Share-Based Compensation - Non-Cash Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NonCashShareBasedCompensationStockOptionsDetails" roleURI="http://www.biohavenpharma.com/role/NonCashShareBasedCompensationStockOptionsDetails">
        <link:definition>9955541 - Disclosure - Non-Cash Share-Based Compensation - Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NonCashShareBasedCompensationRestrictedShareUnitsandPerformanceShareUnitsDetails" roleURI="http://www.biohavenpharma.com/role/NonCashShareBasedCompensationRestrictedShareUnitsandPerformanceShareUnitsDetails">
        <link:definition>9955542 - Disclosure - Non-Cash Share-Based Compensation - Restricted Share Units and Performance Share Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareCalculationofBasicandDilutedNetLossPerShareDetails" roleURI="http://www.biohavenpharma.com/role/NetLossPerShareCalculationofBasicandDilutedNetLossPerShareDetails">
        <link:definition>9955543 - Disclosure - Net Loss Per Share - Calculation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails" roleURI="http://www.biohavenpharma.com/role/NetLossPerShareAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails">
        <link:definition>9955544 - Disclosure - Net Loss Per Share - Antidilutive Securities Excluded from Computation of Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseAcquisitionsandOtherAgreementsDetails" roleURI="http://www.biohavenpharma.com/role/LicenseAcquisitionsandOtherAgreementsDetails">
        <link:definition>9955545 - Disclosure - License, Acquisitions and Other Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseAcquisitionsandOtherAgreementsYaleUniversityAgreementDetails" roleURI="http://www.biohavenpharma.com/role/LicenseAcquisitionsandOtherAgreementsYaleUniversityAgreementDetails">
        <link:definition>9955546 - Disclosure - License, Acquisitions and Other Agreements - Yale University Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseAcquisitionsandOtherAgreementsALSBiopharmaAgreementDetails" roleURI="http://www.biohavenpharma.com/role/LicenseAcquisitionsandOtherAgreementsALSBiopharmaAgreementDetails">
        <link:definition>9955547 - Disclosure - License, Acquisitions and Other Agreements - ALS Biopharma Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseAcquisitionsandOtherAgreementsTaldefgrobepAlfaLicenseAgreementDetails" roleURI="http://www.biohavenpharma.com/role/LicenseAcquisitionsandOtherAgreementsTaldefgrobepAlfaLicenseAgreementDetails">
        <link:definition>9955548 - Disclosure - License, Acquisitions and Other Agreements - Taldefgrobep Alfa License Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseAgreementsHangzhouHighlightllPharmaceuticalAgreementDetails" roleURI="http://www.biohavenpharma.com/role/LicenseAgreementsHangzhouHighlightllPharmaceuticalAgreementDetails">
        <link:definition>9955549 - Disclosure - License Agreements - Hangzhou Highlightll Pharmaceutical Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseAcquisitionsandOtherAgreementsOtherAgreementsDetails" roleURI="http://www.biohavenpharma.com/role/LicenseAcquisitionsandOtherAgreementsOtherAgreementsDetails">
        <link:definition>9955550 - Disclosure - License, Acquisitions and Other Agreements - Other Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseAcquisitionsandOtherAgreementsAcquisitionsDetails" roleURI="http://www.biohavenpharma.com/role/LicenseAcquisitionsandOtherAgreementsAcquisitionsDetails">
        <link:definition>9955551 - Disclosure - License, Acquisitions and Other Agreements - Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.biohavenpharma.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955552 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.biohavenpharma.com/role/RelatedPartyTransactionsDetails">
        <link:definition>9955553 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetails" roleURI="http://www.biohavenpharma.com/role/SegmentInformationDetails">
        <link:definition>9955554 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bhvn_ProceedsFromIssuanceOfCommonStockForLicenseAgreements" abstract="false" name="ProceedsFromIssuanceOfCommonStockForLicenseAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_ChangeInFairValueOfDerivativeLiabilities" abstract="false" name="ChangeInFairValueOfDerivativeLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_FairValueAdjustmentOfNotesPayable" abstract="false" name="FairValueAdjustmentOfNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_LicenseAcquisitionsAndOtherAgreementsTextBlock" abstract="false" name="LicenseAcquisitionsAndOtherAgreementsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bhvn_ScheduleOfMilestonePaymentsTableTextBlock" abstract="false" name="ScheduleOfMilestonePaymentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bhvn_RestrictedCashIncludedInOtherCurrentAssets" abstract="false" name="RestrictedCashIncludedInOtherCurrentAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_MarketableSecuritiesCurrentMember" abstract="true" name="MarketableSecuritiesCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_OtherCurrentAssetsFairValueDisclosure" abstract="false" name="OtherCurrentAssetsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementMember" abstract="true" name="NotePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_FirstNotesMember" abstract="true" name="FirstNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementAggregatePurchasePrice" abstract="false" name="NotePurchaseAgreementAggregatePurchasePrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementAggregatePurchasePriceOffsettingAssetFairValue" abstract="false" name="NotePurchaseAgreementAggregatePurchasePriceOffsettingAssetFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementAggregatePurchasePriceAfterFairValueAdjustment" abstract="false" name="NotePurchaseAgreementAggregatePurchasePriceAfterFairValueAdjustment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_DepreciablePropertyPlantAndEquipmentMember" abstract="true" name="DepreciablePropertyPlantAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_AccruedClinicalTrialCostsCurrent" abstract="false" name="AccruedClinicalTrialCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_AccruedConsiderationTrueUpLiability" abstract="false" name="AccruedConsiderationTrueUpLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_SecondNotesMember" abstract="true" name="SecondNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_ThirdNotesMember" abstract="true" name="ThirdNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_FirstAndThirdNotesMember" abstract="true" name="FirstAndThirdNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementNumberOfPurchases" abstract="false" name="NotePurchaseAgreementNumberOfPurchases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPercentageOfRevenuePaymentsOnNetSales" abstract="false" name="NotePurchaseAgreementPercentageOfRevenuePaymentsOnNetSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementReductionInPercentageOfRevenuePaymentsOnNetSales" abstract="false" name="NotePurchaseAgreementReductionInPercentageOfRevenuePaymentsOnNetSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementMaximumPercentageOfTotalFundedAmountTestDateConditionNotSatisfied" abstract="false" name="NotePurchaseAgreementMaximumPercentageOfTotalFundedAmountTestDateConditionNotSatisfied" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementMaximumPercentageOfRevenuePaymentsOnNetSalesForUnsatisfiedTestDateCondition" abstract="false" name="NotePurchaseAgreementMaximumPercentageOfRevenuePaymentsOnNetSalesForUnsatisfiedTestDateCondition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementMilestonePaymentObligationPercentageOfFunding" abstract="false" name="NotePurchaseAgreementMilestonePaymentObligationPercentageOfFunding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementOneTimePaymentObligationFeeForUnsatisfiedTestDateConditionPercentage" abstract="false" name="NotePurchaseAgreementOneTimePaymentObligationFeeForUnsatisfiedTestDateConditionPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementCapAmountMultiplier" abstract="false" name="NotePurchaseAgreementCapAmountMultiplier" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementCapAmountMultiplierSatisfiedTestDateCondition" abstract="false" name="NotePurchaseAgreementCapAmountMultiplierSatisfiedTestDateCondition" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementUnsatisfiedTestDateConditionTotalPaymentsThresholdPercentage" abstract="false" name="NotePurchaseAgreementUnsatisfiedTestDateConditionTotalPaymentsThresholdPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementCapAmountMultiplierUnsatisfiedTestDateCondition" abstract="false" name="NotePurchaseAgreementCapAmountMultiplierUnsatisfiedTestDateCondition" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementUnsatisfiedTestDateConditionTotalFundedAmountThresholdPercentage" abstract="false" name="NotePurchaseAgreementUnsatisfiedTestDateConditionTotalFundedAmountThresholdPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementCapAmountMultiplierUnsatisfiedTestDateConditionGreaterThanTotalFundedAmountPercentage" abstract="false" name="NotePurchaseAgreementCapAmountMultiplierUnsatisfiedTestDateConditionGreaterThanTotalFundedAmountPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementCapAmountMultiplierUnsatisfiedTestDateConditionLessThanTotalFundedAmountPercentagePriorToEighthAnniversaryOfClosingDate" abstract="false" name="NotePurchaseAgreementCapAmountMultiplierUnsatisfiedTestDateConditionLessThanTotalFundedAmountPercentagePriorToEighthAnniversaryOfClosingDate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementCapAmountMultiplierUnsatisfiedTestDateConditionLessThanTotalFundedAmountPercentageAfterEighthAnniversaryOfClosingDate" abstract="false" name="NotePurchaseAgreementCapAmountMultiplierUnsatisfiedTestDateConditionLessThanTotalFundedAmountPercentageAfterEighthAnniversaryOfClosingDate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementCapAmountMultiplierUnsatisfiedTestDateConditionLessThanTotalFundedAmountPercentage" abstract="false" name="NotePurchaseAgreementCapAmountMultiplierUnsatisfiedTestDateConditionLessThanTotalFundedAmountPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPurchasePricePercentageTotalFundedAmountExerciseOfPutOption" abstract="false" name="NotePurchaseAgreementPurchasePricePercentageTotalFundedAmountExerciseOfPutOption" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPurchasePricePercentageChangeOfControlOrVoluntaryRepurchase" abstract="false" name="NotePurchaseAgreementPurchasePricePercentageChangeOfControlOrVoluntaryRepurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementVoluntaryRepurchasePeriod" abstract="false" name="NotePurchaseAgreementVoluntaryRepurchasePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPurchasePricePercentageRepurchasedPriorToTheEndOfVoluntaryRepurchasePeriod" abstract="false" name="NotePurchaseAgreementPurchasePricePercentageRepurchasedPriorToTheEndOfVoluntaryRepurchasePeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPurchasePricePercentageRepurchasedAfterTheEndOfVoluntaryRepurchasePeriod" abstract="false" name="NotePurchaseAgreementPurchasePricePercentageRepurchasedAfterTheEndOfVoluntaryRepurchasePeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPurchasePricePercentageLessThanTotalFundedAmountRepurchasedAfterThirdAnniversaryOfClosingDate" abstract="false" name="NotePurchaseAgreementPurchasePricePercentageLessThanTotalFundedAmountRepurchasedAfterThirdAnniversaryOfClosingDate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPurchasePricePercentageTotalFundedAmountThresholdPercentage" abstract="false" name="NotePurchaseAgreementPurchasePricePercentageTotalFundedAmountThresholdPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPurchasePricePercentageLessThanTotalFundedAmountRepurchasedPriorToEighthAnniversaryOfClosingDate" abstract="false" name="NotePurchaseAgreementPurchasePricePercentageLessThanTotalFundedAmountRepurchasedPriorToEighthAnniversaryOfClosingDate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPurchasePricePercentageLessThanTotalFundedAmountRepurchasedAfterEighthAnniversaryOfClosingDate" abstract="false" name="NotePurchaseAgreementPurchasePricePercentageLessThanTotalFundedAmountRepurchasedAfterEighthAnniversaryOfClosingDate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPurchasePricePercentageTotalFundedAmountExerciseOfPutOptionRepurchasedAfterFirstAnniversaryButPriorToSecondAnniversary" abstract="false" name="NotePurchaseAgreementPurchasePricePercentageTotalFundedAmountExerciseOfPutOptionRepurchasedAfterFirstAnniversaryButPriorToSecondAnniversary" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPurchasePricePercentageTotalFundedAmountExerciseOfPutOptionRepurchasedAfterSecondAnniversary" abstract="false" name="NotePurchaseAgreementPurchasePricePercentageTotalFundedAmountExerciseOfPutOptionRepurchasedAfterSecondAnniversary" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementPurchasePricePercentageExerciseOfPutOptionGreaterThanTotalFundedAmount" abstract="false" name="NotePurchaseAgreementPurchasePricePercentageExerciseOfPutOptionGreaterThanTotalFundedAmount" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_NotePurchaseAgreementOutstandingAmounts" abstract="false" name="NotePurchaseAgreementOutstandingAmounts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_StockIssuedDuringPeriodSharesCollaborativeArrangement" abstract="false" name="StockIssuedDuringPeriodSharesCollaborativeArrangement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bhvn_StockIssuedDuringPeriodValueCollaborativeArrangement" abstract="false" name="StockIssuedDuringPeriodValueCollaborativeArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_EquityDistributionAgreementMember" abstract="true" name="EquityDistributionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_MaskbegoneAgreementMember" abstract="true" name="MaskbegoneAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_MerusN.V.AgreementMember" abstract="true" name="MerusN.V.AgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_FGFR3AgreementGeneQuantumHealthcareSuzhouCo.Ltd.AndAimedBioInc.Member" abstract="true" name="FGFR3AgreementGeneQuantumHealthcareSuzhouCo.Ltd.AndAimedBioInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_EquityDistributionAgreementMaximumAggregateAvailableAmount" abstract="false" name="EquityDistributionAgreementMaximumAggregateAvailableAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_ObligationToIssueStockSharesObligationArrangement" abstract="false" name="ObligationToIssueStockSharesObligationArrangement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bhvn_ObligationToIssueStockValueObligationArrangement" abstract="false" name="ObligationToIssueStockValueObligationArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExpectedToVestNumberOfShares" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExpectedToVestNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bhvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommonStockReceivableUponVesting" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardCommonStockReceivableUponVesting" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bhvn_ShareBasedAwardsWeightedAverageContractualTermAndAggregateIntrinsicValueAbstract" abstract="true" name="ShareBasedAwardsWeightedAverageContractualTermAndAggregateIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedDevelopmentMilestoneAchievement" abstract="false" name="MilestonePaymentToBePaidByCompanyUponSpecifiedDevelopmentMilestoneAchievement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedRegulatoryMilestoneAchievement" abstract="false" name="MilestonePaymentToBePaidByCompanyUponSpecifiedRegulatoryMilestoneAchievement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedCommercialMilestoneAchievement" abstract="false" name="MilestonePaymentToBePaidByCompanyUponSpecifiedCommercialMilestoneAchievement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_YaleUniversityMember" abstract="true" name="YaleUniversityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_YaleCollaborativeArrangementMember" abstract="true" name="YaleCollaborativeArrangementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_YaleMoDEAgreementMember" abstract="true" name="YaleMoDEAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_MinimumAnnualRoyaltyPaymentToBePaidByCompanyUponSaleOfProduct" abstract="false" name="MinimumAnnualRoyaltyPaymentToBePaidByCompanyUponSaleOfProduct" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_AgreementInitialTerm" abstract="false" name="AgreementInitialTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bhvn_ALSBiopharmaAndFoxChaseChemicalDiversityCenterIncMember" abstract="true" name="ALSBiopharmaAndFoxChaseChemicalDiversityCenterIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_NumberOfProdrugsOfGlutamateModulatingAgents" abstract="false" name="NumberOfProdrugsOfGlutamateModulatingAgents" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bhvn_NumberOfClaimsOfPatentsToReassign" abstract="false" name="NumberOfClaimsOfPatentsToReassign" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bhvn_BMSMember" abstract="true" name="BMSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_TaldefgrobepAlfaLicenseAgreementMember" abstract="true" name="TaldefgrobepAlfaLicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_HighlightllPharmaceuticalCoLtdMember" abstract="true" name="HighlightllPharmaceuticalCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_OtherAgreementsMember" abstract="true" name="OtherAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_UpfrontPaymentsCashPayments" abstract="false" name="UpfrontPaymentsCashPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_UpfrontPaymentsIssuanceOfStock" abstract="false" name="UpfrontPaymentsIssuanceOfStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_UpfrontPaymentsCashPaymentsResearchAndDevelopmentAccrual" abstract="false" name="UpfrontPaymentsCashPaymentsResearchAndDevelopmentAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_PurchaseAgreementKnoppAmendmentMember" abstract="true" name="PurchaseAgreementKnoppAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_PurchaseAgreementKnoppAmendment2025AdditionalConsiderationMember" abstract="true" name="PurchaseAgreementKnoppAmendment2025AdditionalConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_ForwardContractLiability2025AddtionalConsiderationMember" abstract="true" name="ForwardContractLiability2025AddtionalConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_ForwardContractLiability2024AdditionalConsiderationMember" abstract="true" name="ForwardContractLiability2024AdditionalConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_A2024AdditionalConsiderationTrueUpMember" abstract="true" name="A2024AdditionalConsiderationTrueUpMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_A2025AdditionalConsiderationTrueUpMember" abstract="true" name="A2025AdditionalConsiderationTrueUpMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_AcquisitionAxis" abstract="true" name="AcquisitionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bhvn_AcquisitionDomain" abstract="true" name="AcquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_PyramidBiosciencesInc.Member" abstract="true" name="PyramidBiosciencesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_DevelopmentalAndRegulatoryMilestonesFirstAssetMember" abstract="true" name="DevelopmentalAndRegulatoryMilestonesFirstAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_DevelopmentalAndRegulatoryMilestonesSecondAssetMember" abstract="true" name="DevelopmentalAndRegulatoryMilestonesSecondAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_CommercialSalesBasedMilestonesMember" abstract="true" name="CommercialSalesBasedMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_LeadAssetMember" abstract="true" name="LeadAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_SecondAssetMember" abstract="true" name="SecondAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_SuccessBasedMilestonePaymentsToBePaidBasedOnRegulatoryApproval" abstract="false" name="SuccessBasedMilestonePaymentsToBePaidBasedOnRegulatoryApproval" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_AdditionalSuccessBasedMilestonePaymentsToBePaidBasedOnRegulatoryApproval" abstract="false" name="AdditionalSuccessBasedMilestonePaymentsToBePaidBasedOnRegulatoryApproval" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_ObligationForStockIssuablePrivatePlacementPeriod" abstract="false" name="ObligationForStockIssuablePrivatePlacementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bhvn_ForwardContractObligationForStockIssueableValue" abstract="false" name="ForwardContractObligationForStockIssueableValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_ForwardContractObligationForStockIssuableShares" abstract="false" name="ForwardContractObligationForStockIssuableShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bhvn_ForwardContractCurrent" abstract="false" name="ForwardContractCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_WarrantsFairValueDisclosure" abstract="false" name="WarrantsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_AcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" abstract="false" name="AcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bhvn_AcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" abstract="false" name="AcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_AcquisitionContingentConsiderationLiability" abstract="false" name="AcquisitionContingentConsiderationLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_ModaPharmaceuticalsLLCMember" abstract="true" name="ModaPharmaceuticalsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_ModaAgreementMember" abstract="true" name="ModaAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_CambridgeLeaseMember" abstract="true" name="CambridgeLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_OperatingLeaseReductionInSquareFootageAreaOfSpaceLeased" abstract="false" name="OperatingLeaseReductionInSquareFootageAreaOfSpaceLeased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="bhvn_IncreaseDecreaseInRentExpense" abstract="false" name="IncreaseDecreaseInRentExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_RentExpenseAnnualIncreasePercentage" abstract="false" name="RentExpenseAnnualIncreasePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhvn_BHV4157TroriluzoleMember" abstract="true" name="BHV4157TroriluzoleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_BHV2000TaldefgrobepAlfaMember" abstract="true" name="BHV2000TaldefgrobepAlfaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_BHV7000BHV7010Kv7Member" abstract="true" name="BHV7000BHV7010Kv7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_BHV2100BHV2110TRPM3AntagonistMember" abstract="true" name="BHV2100BHV2110TRPM3AntagonistMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_BHV8000TYK2JAK1Member" abstract="true" name="BHV8000TYK2JAK1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_BHV1300IgGDegraderMember" abstract="true" name="BHV1300IgGDegraderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_BHV1310IgGDegraderMember" abstract="true" name="BHV1310IgGDegraderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_BHV1400IgADegraderMember" abstract="true" name="BHV1400IgADegraderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_BHV16001ARAABDegraderMember" abstract="true" name="BHV16001ARAABDegraderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_BHV1510Trop2Member" abstract="true" name="BHV1510Trop2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_BHV1530FGFR3Member" abstract="true" name="BHV1530FGFR3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_OtherRDProgramExpenseMember" abstract="true" name="OtherRDProgramExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhvn_ResearchAndDevelopmentProgramExpense" abstract="false" name="ResearchAndDevelopmentProgramExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_ResearchAndDevelopmentPreclinicalResearchPrograms" abstract="false" name="ResearchAndDevelopmentPreclinicalResearchPrograms" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_ResearchAndDevelopmentExpensePersonnelExpensesExcludingShareBasedCompensation" abstract="false" name="ResearchAndDevelopmentExpensePersonnelExpensesExcludingShareBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_ResearchAndDevelopmentExpenseShareBasedCompensationExpense" abstract="false" name="ResearchAndDevelopmentExpenseShareBasedCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_GeneralAndAdministrativeExpensePersonnelExpenseExcludingShareBasedCompensation" abstract="false" name="GeneralAndAdministrativeExpensePersonnelExpenseExcludingShareBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhvn_GeneralAndAdministrativeExpenseShareBasedCompensation" abstract="false" name="GeneralAndAdministrativeExpenseShareBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
